RecruitingNCT03267615

VICIS - Vienna Cirrhosis Study

Sponsor

Medical University of Vienna

Enrollment

10,000 participants

Start Date

Feb 1, 2017

Study Type

OBSERVATIONAL

Conditions

Ascites Liver Cirrhosis Portal Hypertension Hepatic Encephalopathy Variceal Hemorrhage

Summary

Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - including an optional participation in a biobank. Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital. This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria3

Age \>18 years and \<100 years
Diagnosis of advanced chronic liver disease (by liver stiffness ≥10kPa, HVPG\>5mmHg or Histology F3/F4)
Written informed consent

Exclusion Criteria1

Withdrawal of written informed consent

Locations(1)

Medical University of Vienna

Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03267615

Related Trials

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

NCT074357011 location

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

NCT074399391 location

Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)

NCT074249632 locations

Construction of a Portal Hypertension Biobank

NCT074197241 location

3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

NCT054750151 location